Substance active (DCI)
- sofosbuvir
- daclatasvir
- siméprévir
- association fixe de sofosbuvir et de lédipasvir
- dasabuvir
- association fixe d’ombitasvir, paritaprévir et ritonavir
- -
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
6dPg9jCMmUXFuNmr